Change over period: —
NSE · RELIGARE
RELIGARE ENT
-20.6% from the 52-week high · +9.9% above the low
Religare Enterprises Ltd. is a holding company, which engages in the provision of financial services. The company is headquartered in Noida, Uttar Pradesh and currently employs 34 full-time employees. The company went IPO on 2007-11-21. The firm provides diversified financial services. The firm through its subsidiaries, is primarily engaged in the business of broking in securities and commodities, lending and investments, financial advisory services, distribution of third-party financial products, custodial and depository operations, and health insurance services to its clients. Its segments include investment and financing activities, support services, broking related activities, e-governance, and insurance. Its subsidiaries include Religare Capital Markets International (Mauritius) Limited, Religare Capital Markets (Europe) Limited (RCME), Religare Capital Markets (UK) Limited, Religare Capital Markets Corporate Finance Pte. Ltd., Religare Capital Markets Inc, Tobler UK Limited, Religare Capital Markets (HK) Limited, Religare Capital Markets (Singapore) Pte Limited, and Kyte Management Limited, among others.
The short version. RELIGARE ENT reported revenue of ₹2,381 crore for Sep 2026, up 15.4% from a year earlier. Net profit was ₹-50 crore (down 228.2% year on year). Return on equity was 3.0% in Mar 2026. Promoter holding was 31.26% in Sep 2026, up 31.26 points over 8 quarters.
1 · The price
How has the stock traded?
RELIGARE ENT trades 20.6% below its 52-week high and 9.9% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹2,381 cr.
Sep 2026 net profit of ₹-50 cr.
4.0 pts lower than a year earlier.
Revenue compounded at 20.4% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2381 | 2353 | 2467 | 2056 | 2064 | 1861 | 2028 | 1664 |
| Net profit | -50 | -26 | 82 | -45 | 39 | 10 | 99 | -43 |
| Net margin % | -2.1 | -1.1 | 3.3 | -2.2 | 1.9 | 0.6 | 4.9 | -2.6 |
| EPS (₹) | -1.45 | -0.77 | 2.47 | -1.36 | 1.17 | 0.31 | 3.0 | -1.3 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8459 | 7354 | 6235 | 4676 | 3224 | 2487 | 2355 | 2346 |
| Net profit | 86 | 125 | 233 | 3082 | -1539 | -508 | -932 | -1287 |
| Net margin % | 1.0 | 1.7 | 3.7 | 65.9 | -47.7 | -20.4 | -39.6 | -54.9 |
| EPS (₹) | 2.58 | 3.79 | 7.06 | 95.24 | -48.26 | -19.6 | -36.12 | -59.33 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 3.0% in Mar 2026; debt to equity is 0.14.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 3.0 | 5.0 | 9.9 | 149.8 |
| Return on capital % | 1.0 | 2.9 | 6.3 | 52.2 |
| EBITDA margin % | 2.0 | 4.6 | 9.7 | 81.1 |
| Net margin % | 1.0 | 1.7 | 3.7 | 63.4 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 20.4% | 27.4% |
| Profit CAGR | -69.7% | — |
4 · The owners
Who holds it, and are they adding?
Up 31.26 pts over 8 quarters.
Up 1.72 pts over 8 quarters.
Down 5.62 pts over 8 quarters.
+1 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0 | 25.67 | 25.83 | 25.83 | 26.27 | 30.27 | 30.56 | 31.26 | +31.26 |
| FII | 8.04 | 8.25 | 8.1 | 7.8 | 7.61 | 7.85 | 9.64 | 9.76 | +1.72 |
| DII | 13.14 | 11.76 | 11.62 | 10.27 | 9.32 | 8.52 | 9.33 | 7.52 | -5.62 |
| Public | 78.82 | 54.32 | 54.45 | 56.1 | 56.79 | 53.36 | 50.48 | 51.46 | -27.36 |
Mutual fund holdings · Oct 2026
12 schemes hold this stock
11 the month before.
- SAMCO DYNAMIC ASSET ALLOCATION FUND8.48% of NAV
- SAMCO SPECIAL OPPORTUNITIES FUND6.37% of NAV
- SAMCO ACTIVE MOMENTUM FUND4.22% of NAV
- Motilal Oswal Nifty Microcap 250 Index Fund0.61% of NAV
- Angel One Nifty Total Market Index Fund0.02% of NAV
- Groww Nifty Total Market Index Fund0.02% of NAV
- Angel One Nifty Total Market ETF0.02% of NAV
- Mirae Asset Nifty Total Market Index Fund0.02% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for RELIGARE ENT are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Finance stocks
Quick answers
Common questions about RELIGARE ENT
What is the RELIGARE ENT share price?
RELIGARE ENT (RELIGARE) last closed at ₹230.30, up 4.19% on the day. Its 52-week range is ₹201.11 to ₹278.36.
What is the market cap of RELIGARE ENT?
RELIGARE ENT has a market capitalisation of about ₹8,171 crore.
How are RELIGARE ENT's latest results?
RELIGARE ENT reported revenue of ₹2,381 crore for Sep 2026, up 15.4% from a year earlier. Net profit was ₹-50 crore (down 228.2% year on year). Return on equity was 3.0% in Mar 2026. Promoter holding was 31.26% in Sep 2026, up 31.26 points over 8 quarters.
Who owns RELIGARE ENT?
As of Sep 2026, shareholding was: Promoter 31.26%, FII 9.76%, DII 7.52%, Public 51.46%.
How many mutual funds hold RELIGARE ENT?
12 mutual fund schemes held RELIGARE ENT in October 2026. That compares with 11 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.